Search results
Author(s):
Muthiah Vaduganathan
,
Stefan Anker
,
Javed Butler
,
et al
Added:
1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Dr Scott Isaacs, Prof Peter Rossing, Dr Muthiah Vaduganathan, Prof Stefan Anker and Dr Javed Butler discuss weight management for CRM disease.
View more
Author(s):
Gerasimos Filippatos
,
Gianluigi Savarese
,
,
et al
Added:
1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Prof Gerasimos Filippatos, Dr Manisha Sahay, Prof Gianluigi Savarese, Prof Francesco Cosentino and Prof Sam Seidu discuss multidisciplinary implementation strategies.
View more
Author(s):
Gianluigi Savarese
,
Antonio Ceriello
,
Shelley Zieroth
,
et al
Added:
1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Prof Gianluigi Savarese, Dr Alice Cheng, Dr Adeera Levin, Prof Antonio Ceriello, Dr Shelley Zieroth and Prof Giuseppe Rosano discuss managing patients with CRM.
View more
Author(s):
John GF Cleland
,
Gerasimos Filippatos
,
Ewa Jankowska
,
et al
Added:
1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Prof John Cleland, Prof Gerasimos Filippatos, Prof Ewa Jankowska, Prof David Wheeler, Dr Kieran Docherty discuss anaemia and iron deficiency.
View more
Author(s):
Ileana L Piña
,
Chiadi Ndumele
,
Mitja Lainscak
,
et al
Added:
1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Prof Ahmed Bennis, Dr Ileana L Pina, Dr Giulia Ferrannini, Dr Chiadi Ndumele, Prof Rodica Pop-Busui and Prof Mitja Lainscak discuss the epidemiology and pathophysiology of CRM disease.
View more
Author(s):
Andrew Wang
Added:
8 months ago
AHA Scientific Sessions 2025 – MAPLE-HCM responder analysis shows aficamten monotherapy led to greater treatment effect when compared to metoprolol monotherapy.Dr Andrew Wang (Duke University Medical Center, Durham, NC, US) presents a responder analysis from the MAPLE-HCM trial (NCT05767346), examining clinical responses to aficamten monotherapy versus metoprolol in patients with obstructive…
View more
Author(s):
Gregory Lewis
Added:
9 months ago
HFSA 25 - Aficamten improves excercise capacity compared to metoprolol in patients with obstructive hypertrophic cardiomyopathy in a prespecified analysis of the MAPLE-HCM study.Dr Gregory Lewis joins us to discuss findings from a prespecified cardiopulmonary exercise testing analysis of the MAPLE-HCM trial, which reveals divergent effects between aficamten and metoprolol on exercise performance…
View more
Author(s):
Joost Daemen
,
Nicolas M Van Mieghem
Added:
1 year ago
Keep up to date with the top trials from AHA 24!CLEAR-SYNERGYSELECT-CABGSUMMITYELLOW IIIInternational Aortic Stenosis RegistryAMPLATZER IDEVALOR HCMWatch our full AHA 24 coverage in our Late-Breaking and Featured Science Collection.
View more
Author(s):
Tara Jones
Added:
9 months ago
Learn about revascularisation strategies in cardiogenic shock after acute MI, including culprit-only vs multivessel PCI, from Dr Tara Jones (University of Utah, US).This three-part video lecture series, part of Women As One’s CLIMB® 2025 Skills Training Programme, offers case-based insights into Coronary and Mechanical Support for Cardiogenic Shock, curated by Dr Alison Duncan and Dr Frederick…
View more
Author(s):
Frederick Welt
Added:
9 months ago
Learn about the definition and implications of a shock diagnosis and systems of care and the role of the shock team from Dr Frederick Welt (University of Utah, US).This three-part video lecture series, part of Women As One’s CLIMB® 2025 Skills Training Programme, offers case-based insights into Coronary and Mechanical Support for Cardiogenic Shock, curated by Dr Alison Duncan and Dr Frederick…
View more